Latest News

04.18.19

US Military Develops Mobile Application to Treat Eye Injuries

Source: HIT Infrastructure

04.18.19

Clearside Biomedical Announces Presentations on its Suprachoroidal Space Injection Platform at Upcoming Medical Meetings

Source: Clearside Biomedical

04.18.19

Innovent Announces First Patient Dosed in a Phase 1 Clinical Trial of IBI302 for the Treatment of Wet AMD

Source: Innovent Biologics

04.17.19

GenSight Biologics Reports Positive Follow-Up Results of Phase 3 Trial in LHON

Source: GenSight Biologics

04.17.19

Fraunhofer IAP Developing Contact lenses With Medicine and Sugar

Source: Fraunhofer Institute for Applied Polymer Research IAP

04.17.19

Results of Lumega-Z Data to be Presented at ARVO

Source: Guardion Health Sciences

04.16.19

Ophthotech Changes Name to Iveric bio as it Transitions to Gene Therapy Company

Source: Ophthotech

04.16.19

Visioneering Technologies Creates Educational Series for Eye Care Practitioners

Source: Visioneering Technologies

04.16.19

Proxy Advisory Firms Back Allergan in Battle with Dissident Shareholder Appaloosa

Source: FirstWord

04.16.19

SilkTech Biopharmaceuticals’ IND Submission Cleared by FDA; Phase 2 Clinical Trial Initiated for Patients with Dry Eye Disease

Source: SilkTech Biopharmaceuticals

04.16.19

Oertli Upgrades its Faros Compact Surgical Platform

Source: Oertli Instrumente

04.15.19

Eye Health America Announces Newest Acquisition of Carolinas Centers for Sight

Source: Eye Health America

04.15.19

Ophthotech Obtains Exclusive Global License to AAV Gene Therapy Program for BEST1 Related Retinal Diseases

Source: Ophthotech

04.15.19

NovaBay Pharmaceuticals Announces New Partner Pharmacy Program

Source: NovaBay Pharmaceuticals

04.15.19

Trial Highlights 5-Year Performance of 2 Standalone Glaukos iStents vs. Topical Prostaglandin

Source: Glaukos

View more stories